Suspected BAM type | BAM type 1 (n=107) | BAM type 2 (n=335) | BAM type 3 (n=310) | Overall |
---|---|---|---|---|
SeHCAT % test retention, n (%) | ||||
<5% | 63 (59%) | 47 (14%) | 61 (20%) | 196 (24%) |
5% to <10% | 16 (15%) | 46 (14%) | 44 (15%) | 121 (15%) |
10% to <15% | 6 (5.6%) | 44 (13%) | 31 (10%) | 95 (12%) |
15%+ | 22 (21%) | 189 (58%) | 170 (56%) | 412 (50%) |
Total | 107 | 326 | 306 | 824 |
Centre-defined results, n (%) | ||||
Normal | 22 (21%) | 177 (54%) | 162 (53%) | 388 (47%) |
Borderline | 5 (4.7%) | 20 (6.0%) | 26 (8.4%) | 62 (7.5%) |
Abnormal | 78 (73%) | 118 (36%) | 117 (38%) | 358 (43%) |
Other* | 2 (1.9%) | 14 (4.3%) | 3 (1.0%) | 20 (2.4%) |
Total | 107 | 329 | 308 | 828 |
*Other often described as ‘severe BAM’ or ‘moderate BAM’.
BAM, bile acid malabsorption; SeHCAT, tauroselcholic (75selenium) acid.